Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M308244200 on October 7, 2003

J. Biol. Chem., Vol. 278, Issue 52, 52810-52819, December 26, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/52/52810    most recent
M308244200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Cooper, G. J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Cooper, G. J. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Fibrillogenic Amylin Evokes Islet {beta}-Cell Apoptosis through Linked Activation of a Caspase Cascade and JNK1*

Shaoping Zhang{ddagger}, Junxi Liu{ddagger}, Michael Dragunow§, and Garth J. S. Cooper{ddagger}

From the {ddagger}School of Biological Sciences, Faculty of Science and §Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, 3 Symonds St., Level 4.1, Private Bag 92019, Auckland, New Zealand

Fibrillogenic human amylin elicits pancreatic {beta}-cell apoptosis that may contribute to development of type-2 diabetes. Here, we demonstrated that activation of a caspase cascade is necessary for induction of apoptosis by fibrillogenic amylin variants in two pancreatic {beta}-cell lines. Human amylin, as well as truncated 8–37human amylin, evoked sequential activation of caspases-8 and -3, and apoptosis, whereas non-{beta}-sheet forming and non-fibrillogenic homologs, such as [25,28,29triprolyl]human amylin, did not, implying that the {beta}-sheet conformer is required for human amylin-induced caspase activation. Significant inhibition of apoptosis was evoked by a selective caspase-1 inhibitor, indicating that caspase-1 is also essential for activation of the caspase cascade. Furthermore, we showed that specific jnk1 antisense oligonucleotides, which suppress phospho-JNK1 expression, effectively decreased human amylin-induced activation of c-Jun. Studies of the interplay between the caspase cascade and the JNK pathway showed that both apoptosis and caspase-3 activation were suppressed by treatment with a JNK inhibitor and by transfection of antisense jnk1 oligonucleotides or antisense-c-jun, whereas a selective inhibitor of caspases-1 and -3 prevented apoptosis but not c-Jun activation. Thus, the JNK1 activation preceded activation of caspases-1 and -3. However, selective JNK inhibition had no effect on caspase-8 activation, and selective caspase-8 inhibition only partially suppressed apoptosis and c-Jun activation, indicating that caspase-8 may partially act upstream of the JNK pathway. Our studies demonstrate a functional interaction of a caspase cascade and JNK1. Fibrillogenic amylin can evoke a JNK1-mediated apoptotic pathway, which is partially dependent and partially independent of caspase-8, and in which caspase-3 acts as a common downstream effector.


Received for publication, July 29, 2003 , and in revised form, October 1, 2003.

* This work was supported by the Endocore Research Trust, the Maurice & Phyllis Paykel Trust, and the New Zealand Lottery Grants Board, and by a New Zealand Health Research Council grant (to M. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Tel.: 64-9-373-7599 (ext. 87239); Fax: 64-9-373-7045; E-mail: g.cooper{at}auckland.ac.nz.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. Bonner-Weir and T. D. O'Brien
Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner
Diabetes, November 1, 2008; 57(11): 2899 - 2904.
[Full Text] [PDF]


Home page
DiabetesHome page
L. Marzban, A. Tomas, T. C. Becker, L. Rosenberg, J. Oberholzer, P. E. Fraser, P. A. Halban, and C. B. Verchere
Small Interfering RNA-Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in Culture
Diabetes, November 1, 2008; 57(11): 3045 - 3055.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W. P.S. Wong, D. W. Scott, C.-L. Chuang, S. Zhang, H. Liu, A. Ferreira, E. L. Saafi, Y. S. Choong, and G. J.S. Cooper
Spontaneous Diabetes in Hemizygous Human Amylin Transgenic Mice That Developed Neither Islet Amyloid nor Peripheral Insulin Resistance
Diabetes, October 1, 2008; 57(10): 2737 - 2744.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Mokhtari, J. W. Myers, and N. Welsh
MAPK Kinase Kinase-1 Is Essential for Cytokine-Induced c-Jun NH2-Terminal Kinase and Nuclear Factor-{kappa}B Activation in Human Pancreatic Islet Cells
Diabetes, July 1, 2008; 57(7): 1896 - 1904.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Mokhtari, J. W. Myers, and N. Welsh
The MAPK Kinase Kinase-1 Is Essential for Stress-Induced Pancreatic Islet Cell Death
Endocrinology, June 1, 2008; 149(6): 3046 - 3053.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Haataja, T. Gurlo, C. J. Huang, and P. C. Butler
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Endocr. Rev., May 1, 2008; 29(3): 303 - 316.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Zhang, H. Liu, H. Yu, and G. J.S. Cooper
Fas-Associated Death Receptor Signaling Evoked by Human Amylin in Islet {beta}-Cells
Diabetes, February 1, 2008; 57(2): 348 - 356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C.-j. Huang, L. Haataja, T. Gurlo, A. E. Butler, X. Wu, W. C. Soeller, and P. C. Butler
Induction of endoplasmic reticulum stress-induced -cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1656 - E1662.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. H. Jhamandas and D. MacTavish
Antagonist of the Amylin Receptor Blocks {beta}-Amyloid Toxicity in Rat Cholinergic Basal Forebrain Neurons
J. Neurosci., June 16, 2004; 24(24): 5579 - 5584.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement